Is Spruce Biosciences Inc (NASDAQ: SPRB) Still On The Rise?

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Yahoo Finance discussed the stock recently as it posted Spruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $0.79 and fluctuated between $0.7994 as its day high and $0.7300 as its day low. The current market capitalization of Spruce Biosciences Inc is $32.34M. A total of 1.37 million shares were traded on the day, compared to an average of 1.20M shares.

In the most recent transaction, Novo Holdings A/S sold 465,021 shares of SPRB for 0.75 per share on Mar 21 ’24. After the transaction, the 10% Owner now owns 2,550,000 company shares. In a previous transaction on Mar 20 ’24, Novo Holdings A/S sold 359,979 shares at 0.73 per share. SPRB shares that 10% Owner owns now total 3,015,021.

Among the insiders who sold shares, Novo Holdings A/S disposed of 593,000 shares on Mar 19 ’24 at a per-share price of $0.76. This resulted in the 10% Owner holding 3,375,000 shares of SPRB after the transaction. In another insider transaction, Novo Holdings A/S sold 842,020 shares at $0.77 per share on Mar 18 ’24. Company shares held by the 10% Owner now total 3,968,000.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, SPRB has a high of $5.95 and a low of $0.68.

As of this writing, SPRB has an earnings estimate of -$0.29 per share for the current quarter. EPS was calculated based on a consensus of 7 estimates, with a high estimate of -$0.19 per share and a lower estimate of -$0.34. The company reported an EPS of -$0.3 in the last quarter, which was 14.30% higher than expectations of -$0.35.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. SPRB’s latest balance sheet shows that the firm has $88.97M in Cash & Short Term Investments as of fiscal 2021. There were $6.53M in debt and $8.87M in liabilities at the time. Its Book Value Per Share was $1.86, while its Total Shareholder’s Equity was $111.37M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SPRB is Buy with a score of 3.57.

Most Popular

Related Posts